A phase II multi-center study of bevacizumab in combination with ixabepilone in subjects with advanced renal cell carcinoma

Mauricio Burotto^*, Maureen Edgerly, Margarita Velarde, Sanjeeve Balasubramaniam, Harry Drabkin, Juan G. Gormaz, Ciara O’Sullivan, Ravi Madan, Tito Fojo

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review